Is active surveillance an option for metachronous metastatic renal cell carcinoma?
作者信息
Ficarra Vincenzo, Mosca Alessandra, Rossanese Marta, Subba Enrica, Giannarini Gianluca
机构信息
Department of Human and Pediatric Pathology "Gaetano Barresi", Urologic Section, University of Messina, Messina, Italy.
Oncology Unit, Maggiore della Carità University Hospital, Novara, Italy.
出版信息
Ann Transl Med. 2019 Mar;7(5):84. doi: 10.21037/atm.2019.01.08.
Abstract
摘要
相似文献
1
Is active surveillance an option for metachronous metastatic renal cell carcinoma?
Ann Transl Med. 2019 Mar;7(5):84. doi: 10.21037/atm.2019.01.08.
2
Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
Cancer. 2019 Jan 15;125(2):232-238. doi: 10.1002/cncr.31689. Epub 2018 Dec 18.
3
Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception?
Eur Urol. 2017 May;71(5):e139-e140. doi: 10.1016/j.eururo.2016.09.034. Epub 2016 Sep 29.
4
Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
J Urol. 2007 Jun;177(6):2081-6; discussion 2086-7. doi: 10.1016/j.juro.2007.01.122.
5
Metachronous pancreatic metastases from renal cell carcinoma: is there a place of Active-Surveillance before deferred deliberately Molecular Target Agent?
World J Surg Oncol. 2016 Aug 23;14(1):222. doi: 10.1186/s12957-016-0939-9.
6
Metachronous renal cell carcinoma with metastasis to the urinary bladder, and distant organs, 28 years after radical nephrectomy: a case report.
BMC Urol. 2019 Dec 27;19(1):136. doi: 10.1186/s12894-019-0521-1.
7
Metachronous metastasis of renal cell carcinoma to the urinary bladder: a case report.
Ther Adv Urol. 2017 Nov 3;10(1):29-32. doi: 10.1177/1756287217738986. eCollection 2018 Jan.
8
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
J Urol. 2008 May;179(5):1719-26. doi: 10.1016/j.juro.2008.01.018. Epub 2008 Mar 17.
9
Metachronous isolated locally advanced pancreatic metastasis from chromophobe renal cell carcinoma.
Int J Surg Case Rep. 2019;60:196-199. doi: 10.1016/j.ijscr.2019.05.046. Epub 2019 Jun 5.
10
Surgical resection of metastatic renal cell carcinoma: The University of Iowa experience.
Urol Oncol. 1997 May-Jun;3(3):99-101. doi: 10.1016/s1078-1439(97)00062-8.
引用本文的文献
1
De Novo Renal Cell Carcinoma in Kidney Transplant Recipients: Incidence, Outcomes, and Therapeutic Challenges.
Cancers (Basel). 2025 Jun 30;17(13):2200. doi: 10.3390/cancers17132200.
2
Comorbidity and frailty assessment in renal cell carcinoma patients.
World J Urol. 2021 Aug;39(8):2831-2841. doi: 10.1007/s00345-021-03632-6. Epub 2021 Feb 22.
本文引用的文献
1
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma.
Urol Oncol. 2018 Dec;36(12):526.e13-526.e18. doi: 10.1016/j.urolonc.2018.08.018. Epub 2018 Oct 6.
2
Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study.
Clin Genitourin Cancer. 2018 Dec;16(6):e1221-e1235. doi: 10.1016/j.clgc.2018.08.001. Epub 2018 Aug 25.
3
Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors.
Anticancer Res. 2018 Jan;38(1):359-365. doi: 10.21873/anticanres.12230.
4
Renal cell carcinoma.
Nat Rev Dis Primers. 2017 Mar 9;3:17009. doi: 10.1038/nrdp.2017.9.
5
Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception?
Eur Urol. 2017 May;71(5):e139-e140. doi: 10.1016/j.eururo.2016.09.034. Epub 2016 Sep 29.
6
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2016 Sep;27(suppl 5):v58-v68. doi: 10.1093/annonc/mdw328.
7
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial.
Lancet Oncol. 2016 Sep;17(9):1317-24. doi: 10.1016/S1470-2045(16)30196-6. Epub 2016 Aug 3.
8
Local treatments for metastases of renal cell carcinoma: a systematic review.
Lancet Oncol. 2014 Nov;15(12):e549-61. doi: 10.1016/S1470-2045(14)70235-9. Epub 2014 Oct 26.
9
Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.
J Urol. 2015 Mar;193(3):776-82. doi: 10.1016/j.juro.2014.09.020. Epub 2014 Sep 18.
10
Kidney cancer: Characterizing late recurrence of renal cell carcinoma.
Nat Rev Urol. 2013 Dec;10(12):687-9. doi: 10.1038/nrurol.2013.239. Epub 2013 Oct 29.
Zotero 插件